about
Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathwaysEosinophilia Associated with Disorders of Immune Deficiency or Immune DysregulationImmunotherapy in autoimmune type 1 diabetesAutosomal dominant immune dysregulation syndrome in humans with CTLA4 mutationsIdentification of novel genes and transcription factors involved in spleen, thymus and immunological development and function.A remarkable depletion of both naïve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain.Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatmentDomain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expressionLncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn's disease.Perspectives on Regulatory T Cell Therapies.Treg vaccination with a strong-agonistic insulin mimetope.Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathwayTh17 immune responses contribute to the pathophysiology of aplastic anemia.The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDSDefective regulatory and effector T cell functions in patients with FOXP3 mutations.Primary immunodeficiencies: a field in its infancy.Treg vaccination in autoimmune type 1 diabetes.The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells.Functional role of regulatory lymphocytes in stroke: facts and controversies.CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis.Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras.Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell developmentRole of CD28 in fatal autoimmune disorder in scurfy mice.Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.Molecular defects in T- and B-cell primary immunodeficiency diseases.Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathwayStrong-arming immune regulation: suppressing regulatory T-cell function to treat cancers.Immunity to microbes: lessons from primary immunodeficiencies.Regulation of apoptosis-related genes by nitric oxide in cancer.Regulatory T cells and toll-like receptors: regulating the regulatorsTargeting regulatory T cells in the treatment of type 1 diabetes mellitus.Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis.Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes.Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signalingGenetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.Gene expression patterns and susceptibility to allergic responses.Physiological and pathophysiological functions of SOCE in the immune system.Laboratory diagnosis of primary immunodeficiencies.
P2860
Q24323279-B20EF8FE-434A-4D0E-B664-116C74CFD7A0Q26799603-EBC406FC-B411-49F0-864F-9FE969623613Q27025619-E6253884-17EA-45BF-9713-A032FBA52CFAQ28250000-5B738CD1-1B0C-402F-A644-0B7F8290E136Q33229483-BEB3ECF2-C34D-4CB4-80FE-621540EAEAD2Q33379659-67D2E50C-8E6C-48D4-85BF-994B910E52C0Q33417357-C4DF7FA7-B4F3-4DFE-A01A-C85C32946513Q33517120-C4C4B78A-229B-437A-A29F-4C8D1C26330EQ33639952-18B5FBAF-5F9A-4CA3-A3DA-8369B29221D8Q34242712-499AA7F4-2F86-456D-A260-CF58FE4F33C8Q34263542-570A2A59-B271-4466-BE51-1660FAD66896Q34327132-21CA728D-16BF-474F-9A65-DE0F1EBB1430Q34340613-2A2F5028-723D-4307-B1A0-9F0E7EADD51CQ34360341-4C8FA285-3E00-4048-A53E-B3C91B288FD9Q34606553-A7C0F743-7245-409B-99A1-FC88D2E1B606Q34648860-7D3B530E-2A09-419E-AFA6-358FACBEE7B8Q34659118-54133BBE-BC9F-4653-84AF-CE035C5FC70EQ34957397-14B9A03E-4215-43A6-886F-299D4ED1789FQ35015109-2DA7D53C-2F53-484E-A088-855A73F9E070Q35554595-C52D19F4-CD0D-4017-9DFA-2C1890E044DAQ35621197-AC711CDE-61D1-4D8E-9AB1-094DA5862CD5Q35829151-27D3DB15-2C71-471B-89A3-413E0406C3ABQ35848780-ECDBB06A-82A6-45B5-89A2-3BD2325A9A59Q35925037-FC341F5A-D3DA-4E6A-A963-C9017E90EB2BQ35956613-65F97CD1-DAD8-41BA-8EB1-05D4E0DA6404Q36228688-E869AD7A-8FA4-43EB-9E4D-9C432A7ABA1FQ36302334-BE3CEDDF-793E-461D-BBEB-0E62137697DAQ36407194-1578659E-AF6B-44B2-8381-B7EFA74495DBQ36512526-7356082D-9DA5-4534-A433-EC85352DD6B2Q36729350-DBE3BB57-3883-4A2F-9CE8-BAC10E9B89B0Q36876734-F7A36C2B-709B-4356-84AA-150D4D478DECQ36969926-07360727-BC21-433D-A12E-55156C0847ECQ37006155-BF5C0468-A767-46B9-95AC-3108F159BFC1Q37231889-BA9D3A8C-7B94-4BF9-ABC0-93DAEF6EF00EQ37252438-93FB9303-DA5E-4FD2-8576-46D50771EFCCQ37550184-4A2133A9-3A6C-410F-8894-B4C0EC5275C9Q37725869-3D1A0721-A7B3-4D2B-B1EC-BFC2FBC3DA36Q37754742-247A2710-4A79-420E-8916-4B944A64DFA0Q37971728-31343C8F-1CAD-47DD-A4AC-37224197806CQ38191164-5C90058C-A6AF-4C5F-BF13-2746FE80A190
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
FOXP3 acts as a rheostat of the immune response.
@ast
FOXP3 acts as a rheostat of the immune response.
@en
type
label
FOXP3 acts as a rheostat of the immune response.
@ast
FOXP3 acts as a rheostat of the immune response.
@en
prefLabel
FOXP3 acts as a rheostat of the immune response.
@ast
FOXP3 acts as a rheostat of the immune response.
@en
P2093
P2860
P1476
FOXP3 acts as a rheostat of the immune response.
@en
P2093
Hans D Ochs
Steven F Ziegler
Troy R Torgerson
P2860
P304
P356
10.1111/J.0105-2896.2005.00231.X
P577
2005-02-01T00:00:00Z